Cost-Minimisation Analysis of Sucroferric Oxhydroxide and Sevelamer Carbonate in Patients on Dialysis with Secondary Hyperparathyroidism in Six European Countries
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1001
https://www.valueinhealthjournal.com/article/S1098-3015(16)32367-1/fulltext
Title :
Cost-Minimisation Analysis of Sucroferric Oxhydroxide and Sevelamer Carbonate in Patients on Dialysis with Secondary Hyperparathyroidism in Six European Countries
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32367-1&doi=10.1016/j.jval.2016.09.1001
First page :
A519
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
942